Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 1232

1.

Effectiveness of resistance exercise compared to aerobic exercise without insulin therapy in patients with type 2 diabetes mellitus: a meta-analysis.

Nery C, Moraes SRA, Novaes KA, Bezerra MA, Silveira PVC, Lemos A.

Braz J Phys Ther. 2017 Jul 5. pii: S1413-3555(17)30243-5. doi: 10.1016/j.bjpt.2017.06.004. [Epub ahead of print] Review.

PMID:
28728958
2.

Effectiveness of bariatric procedures based on selected laboratory parameters of patients from rural areas in Polish population.

Sierżantowicz R, Lewko J, Trochimowicz L, Kirpsza B, Dadan J, Hady HR.

Adv Clin Exp Med. 2017 Jun 27. doi: 10.17219/acem/67150. [Epub ahead of print]

PMID:
28691429
3.

Are visceral adiposity index and lipid accumulation product reliable indices for metabolic disturbances in patients with type 2 diabetes mellitus?

Kavaric N, Klisic A, Ninic A.

J Clin Lab Anal. 2017 Jun 20. doi: 10.1002/jcla.22283. [Epub ahead of print]

PMID:
28632304
4.

A risk-score model for predicting risk of type 2 diabetes mellitus in a rural Chinese adult population: A cohort study with a 6-year follow-up.

Zhang H, Wang C, Ren Y, Wang B, Yang X, Zhao Y, Han C, Zhou J, Zhang L, Qi M, Zhai Y, Pang C, Yin L, Zhao J, Hu D, Zhang M.

Diabetes Metab Res Rev. 2017 Jun 13. doi: 10.1002/dmrr.2911. [Epub ahead of print]

PMID:
28608942
5.

Anti-obesogenic and hypolipidemic effects of a glucagon-like peptide-1 receptor agonist derived from the saliva of the Gila monster.

Alves PL, Abdalla FMF, Alponti RF, Silveira PF.

Toxicon. 2017 Sep 1;135:1-11. doi: 10.1016/j.toxicon.2017.06.001. Epub 2017 Jun 1.

PMID:
28579479
6.

Alterations in Plasma Triglyceride Concentrations following Two Oral Meals with Different Fat Content in Patients with Type 2 Diabetes Mellitus.

Gavra P, Mellidonis A, Iraklianou S, Mihas C, Kolovou V, Mavrogeni S, Dimitriadis G, Rallidis L, Vasaramva K, Boutati E, Katsiki N, Kolovou G.

Curr Vasc Pharmacol. 2017 May 28. doi: 10.2174/1570161115666170529084621. [Epub ahead of print]

PMID:
28552072
7.

Depression and alexithymia on weight perception in patients with metabolic syndrome and type 2 diabetes.

de Oliveira Regina MC, Tambascia MA.

Diabetol Metab Syndr. 2017 May 12;9:34. doi: 10.1186/s13098-017-0222-4. eCollection 2017.

8.

Plasminogen Activator Inhibitor-1 and Pericardial Fat in Individuals with Type 2 Diabetes Mellitus.

Bayomy O, Rao AD, Garg R, Vaidya A, Kotin AR, Reiber B, Nijmeijer S, Di Carli MF, Jerosch-Herold M, Kwong RY, Adler GK.

Metab Syndr Relat Disord. 2017 May 15. doi: 10.1089/met.2017.0031. [Epub ahead of print]

PMID:
28504921
9.

Low levels of ApoA1 improve risk prediction of type 2 diabetes mellitus.

Wu X, Yu Z, Su W, Isquith DA, Neradilek MB, Lu N, Gu F, Li H, Zhao XQ.

J Clin Lipidol. 2017 Mar - Apr;11(2):362-368. doi: 10.1016/j.jacl.2017.01.009. Epub 2017 Jan 25.

10.

Histologic Scores for Fat and Fibrosis Associate With Development of Type 2 Diabetes in Patients With Nonalcoholic Fatty Liver Disease.

Björkström K, Stål P, Hultcrantz R, Hagström H.

Clin Gastroenterol Hepatol. 2017 May 4. pii: S1542-3565(17)30534-7. doi: 10.1016/j.cgh.2017.04.040. [Epub ahead of print]

PMID:
28479500
11.

Effect of a Pharmacist-Led Program on Improving Outcomes in Patients with Type 2 Diabetes Mellitus from Northern Cyprus: A Randomized Controlled Trial.

Korcegez EI, Sancar M, Demirkan K.

J Manag Care Spec Pharm. 2017 May;23(5):573-582. doi: 10.18553/jmcp.2017.23.5.573.

12.

AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF DYSLIPIDEMIA AND PREVENTION OF CARDIOVASCULAR DISEASE.

Jellinger PS, Handelsman Y, Rosenblit PD, Bloomgarden ZT, Fonseca VA, Garber AJ, Grunberger G, Guerin CK, Bell DSH, Mechanick JI, Pessah-Pollack R, Wyne K, Smith D, Brinton EA, Fazio S, Davidson M.

Endocr Pract. 2017 Apr;23(Suppl 2):1-87. doi: 10.4158/EP171764.APPGL.

PMID:
28437620
13.

Gender dependent effects of fasting blood glucose levels and disease duration on biochemical markers in type 2 diabetics: A pilot study.

Ghadge AA, Diwan AG, Harsulkar AM, Kuvalekar AA.

Diabetes Metab Syndr. 2017 Apr 7. pii: S1871-4021(17)30017-6. doi: 10.1016/j.dsx.2017.03.041. [Epub ahead of print]

PMID:
28431918
14.

Metabolic syndrome, serum uric acid and renal risk in patients with T2D.

Viazzi F, Piscitelli P, Giorda C, Ceriello A, Genovese S, Russo G, Guida P, Fioretto P, De Cosmo S, Pontremoli R; AMD-Annals Study Group.

PLoS One. 2017 Apr 19;12(4):e0176058. doi: 10.1371/journal.pone.0176058. eCollection 2017.

15.

Education achievement and type 2 diabetes-what mediates the relationship in older adults? Data from the ESTHER study: a population-based cohort study.

Steele CJ, Schöttker B, Marshall AH, Kouvonen A, O'Doherty MG, Mons U, Saum KU, Boffetta P, Trichopoulou A, Brenner H, Kee F.

BMJ Open. 2017 Apr 17;7(4):e013569. doi: 10.1136/bmjopen-2016-013569.

16.

Enlarged waist combined with elevated triglycerides (hypertriglyceridemic waist phenotype) and HDL-cholesterol in patients with heart failure.

Weschenfelder C, Marcadenti A, Stein AT, Gottschall CB.

Sao Paulo Med J. 2017 Jan-Feb;135(1):50-56. doi: 10.1590/1516-3180.2016.004519102016.

17.
18.

Differential sex effects of systolic blood pressure and low-density lipoprotein cholesterol on type 2 diabetes: Life course data from the Bogalusa Heart Study.

Pollock BD, Chen W, Harville EW, Shu T, Fonseca V, Mauvais-Jarvis F, Kelly TN, Bazzano LA.

J Diabetes. 2017 Feb 27. doi: 10.1111/1753-0407.12543. [Epub ahead of print]

PMID:
28239958
19.

Bariatric Surgery versus Intensive Medical Therapy for Diabetes - 5-Year Outcomes.

Schauer PR, Bhatt DL, Kirwan JP, Wolski K, Aminian A, Brethauer SA, Navaneethan SD, Singh RP, Pothier CE, Nissen SE, Kashyap SR; STAMPEDE Investigators.

N Engl J Med. 2017 Feb 16;376(7):641-651. doi: 10.1056/NEJMoa1600869.

20.

Canagliflozin improves risk factors of metabolic syndrome in patients with type 2 diabetes mellitus and metabolic syndrome.

Davies MJ, Merton KW, Vijapurkar U, Balis DA, Desai M.

Diabetes Metab Syndr Obes. 2017 Jan 27;10:47-55. doi: 10.2147/DMSO.S126291. eCollection 2017.

Supplemental Content

Loading ...
Support Center